Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting roughly 1 in 10 worldwide. Despite that prevalence, many women wait years for a proper diagnosis. This guide covers what PCOS actually is, how it gets diagnosed, why insulin resistance sits at the center of most symptoms, and what treatment options exist in 2026, including the growing use of GLP-1 medications.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey, and you can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
PCOS is a hormonal condition defined by the Rotterdam criteria, established in 2003, which require at least two of three features: irregular or absent ovulation, elevated androgens (either by blood test or clinical signs like excess hair growth), and polycystic-appearing ovaries on ultrasound.<\/strong> You don’t need all three. You don’t even need cysts on your ovaries to have PCOS.<\/p>\n Quick Answer: PCOS affects 1 in 10 women, but up to 70% remain undiagnosed for an average of 2+ years.<\/p>\n The Rotterdam criteria replaced the older NIH criteria from 1990, which were stricter and missed a lot of women. The 2003 update recognized that PCOS presents differently in different people. Some women have all three features. Others have irregular periods and high testosterone but normal-looking ovaries. Both count.<\/p>\n The numbers depend on which diagnostic criteria you use. Under the Rotterdam criteria, prevalence runs between 8% and 13% of reproductive-age women globally, according to a 2018 systematic review published in Human Reproduction Update by Bozdag et al. The WHO estimates over 116 million women are affected worldwide.<\/p>\n Here’s the problem with those numbers: up to 70% of women with PCOS remain undiagnosed. A 2017 study in the Journal of Clinical Endocrinology & Metabolism by Gibson-Helm et al. found that women visited an average of 3.1 healthcare providers before getting their PCOS diagnosis, and nearly a third waited more than two years.<\/p>\n That delay matters. Unmanaged PCOS increases the risk of type 2 diabetes, cardiovascular disease, endometrial cancer, depression, and infertility. Earlier diagnosis means earlier intervention.<\/p>\n The name “polycystic ovary syndrome” is misleading, and there’s been ongoing debate about renaming it. The “cysts” on the ovaries aren’t actually cysts. They’re small antral follicles that failed to mature. And the condition involves far more than the ovaries. In 2023, an international evidence-based guideline endorsed by multiple medical societies (led by Monash University) recommended against renaming for now, primarily because a name change could disrupt existing research and coding systems. But the conversation isn’t over.<\/p>\n Insulin resistance is present in 65% to 80% of women with PCOS, regardless of body weight.<\/strong> This is the engine driving most PCOS symptoms, and understanding it changes how you think about treatment.<\/p>\n When cells don’t respond properly to insulin, the pancreas compensates by producing more of it. High circulating insulin does two damaging things in PCOS. First, it stimulates the ovaries to produce excess testosterone. Second, it suppresses sex hormone-binding globulin (SHBG), the protein that normally keeps testosterone inactive in the bloodstream. The result: more testosterone produced and more of it available to cause problems.<\/p>\n A 2012 study by Diamanti-Kandarakis and Dunaif published in Endocrine Reviews confirmed that insulin resistance in PCOS is partly intrinsic (meaning it exists independent of obesity) and partly exacerbated by excess weight. This is why lean women can have PCOS with insulin resistance, and why weight gain makes an existing condition worse.<\/p>\n You might not feel anything specific. But common signs include:<\/p>\n Standard fasting glucose tests often miss insulin resistance in its early stages. A two-hour oral glucose tolerance test (OGTT) with insulin levels, or a fasting insulin with HOMA-IR calculation, gives a better picture. If your HOMA-IR is above 2.5, insulin resistance is likely. Above 3.0 and it’s pretty definitive.<\/p>\n PCOS symptoms vary from person to person, but they cluster into a few categories.<\/strong> The combination matters more than any single symptom.<\/p>\n This is the most obvious sign. Some women have cycles longer than 35 days. Others skip months entirely. Some have periods that come unpredictably. Anything fewer than 8 cycles per year qualifies as oligomenorrhea.<\/p>\n The reason is anovulation: the follicles start developing but don’t mature enough to release an egg. Without ovulation, progesterone doesn’t rise, and the uterine lining either doesn’t shed on schedule or builds up excessively.<\/p>\n About 60% to 70% of women with PCOS develop hirsutism, meaning coarse, dark hair in places like the chin, upper lip, chest, back, or abdomen. This is caused by elevated androgens acting on hair follicles. The modified Ferriman-Gallwey score is used to grade severity; a score of 8 or above (out of 36) generally indicates clinical hirsutism.<\/p>\n Androgen-driven acne tends to appear along the jawline, chin, and lower face. It’s often deep, cystic, and doesn’t respond well to standard topical treatments. This type of acne typically starts or worsens in the late teens to mid-twenties, unlike typical adolescent acne that peaks earlier.<\/p>\n Approximately 40% to 80% of women with PCOS are overweight or obese, and the weight tends to concentrate around the midsection. But the relationship goes both ways. PCOS makes it harder to lose weight because of insulin resistance and altered appetite hormones, and excess weight worsens insulin resistance. It’s a feedback loop.<\/p>\n A 2020 meta-analysis by Lim et al. in Obesity Reviews found that women with PCOS have a resting metabolic rate roughly 40 calories per day lower than weight-matched women without PCOS. That doesn’t sound like much, but over a year it compounds, and it’s on top of the behavioral effects of insulin resistance on hunger and cravings.<\/p>\n While excess body and facial hair increases, scalp hair often thins. The pattern is typically diffuse thinning across the crown rather than the receding hairline pattern seen in men. About 22% of women with PCOS experience some degree of androgenic alopecia according to a 2019 review in the International Journal of Women’s Dermatology.<\/p>\n PCOS is the most common cause of anovulatory infertility. Without regular ovulation, conception becomes difficult or impossible without intervention. The good news: PCOS-related infertility is often treatable, and many women with PCOS do conceive, sometimes with lifestyle changes alone.<\/p>\n This one gets underappreciated. A 2020 meta-analysis by Cooney et al. in Fertility and Sterility found that women with PCOS have a 3.78-fold increased risk of depression and a 5.62-fold increased risk of anxiety compared to women without PCOS. These aren’t just reactions to the cosmetic symptoms. Insulin resistance, chronic low-grade inflammation, and altered neurotransmitter signaling all contribute directly to mood disturbance.<\/p>\n Weight loss of even 5% to 10% of body weight can restore ovulation, improve insulin sensitivity, lower testosterone levels, and reduce cardiovascular risk in women with PCOS.<\/strong> This finding has been replicated in multiple studies going back decades, including a landmark 2004 study by Crosignani et al. in Human Reproduction.<\/p>\n That 5% threshold is important because it’s achievable. For a 200-pound woman, that’s 10 to 20 pounds. Not a transformation. Not a goal weight. Just enough to shift the metabolic needle.<\/p>\n The problem is that PCOS makes weight loss harder than it is for the general population. The insulin resistance, the lower metabolic rate, the increased hunger hormones, the fatigue, the depression. Women with PCOS aren’t failing at weight loss because they lack willpower. The deck is stacked against them biochemically.<\/p>\n This is exactly why pharmacological tools, including GLP-1 medications, have become increasingly important in PCOS management.<\/p>\n PCOS treatment is individualized based on which symptoms are most bothersome and what the patient’s goals are, particularly regarding fertility.<\/strong> There’s no single drug that treats everything.<\/p>\n Diet and exercise remain the foundation. The 2023 international PCOS guideline recommends lifestyle intervention as first-line treatment for all women with PCOS, regardless of BMI.<\/p>\n The specifics matter. For diet, evidence supports low glycemic index approaches over generic calorie restriction. A 2010 study by Marsh et al. in the American Journal of Clinical Nutrition showed that a low-GI diet improved insulin sensitivity and menstrual regularity more than a conventional healthy diet, even when calorie intake was the same.<\/p>\n Exercise recommendations for PCOS include at least 150 minutes per week of moderate-intensity activity or 75 minutes of vigorous activity, with two sessions of resistance training. More on exercise specifics appears in our PCOS exercise guide.<\/p>\n Metformin was the first drug widely used off-label for PCOS, starting in the 1990s. It works as an insulin sensitizer, reducing hepatic glucose production and improving peripheral insulin sensitivity. The typical dose is 1500 to 2000 mg daily, titrated slowly to minimize GI side effects.<\/p>\n Does it work? Yes, but with caveats. The 2007 study by Legro et al. in the New England Journal of Medicine compared metformin to clomiphene for infertility in PCOS and found that metformin alone was significantly less effective than clomiphene for achieving live births (7.2% vs 22.5%). But metformin does improve menstrual regularity, lower testosterone, and help with modest weight loss (average 2-3 kg over 6 months).<\/p>\n Metformin’s biggest role in PCOS may be diabetes prevention. The Diabetes Prevention Program (DPP) trial showed that metformin reduced progression to type 2 diabetes by 31% in high-risk populations, and women with PCOS-like characteristics benefited disproportionately.<\/p>\n Combined oral contraceptives (COCs) are the most commonly prescribed treatment for PCOS in women not trying to conceive. They regulate periods, reduce androgen levels, clear acne, and slow hirsutism. The estrogen component raises SHBG, binding up free testosterone. The progestin component opposes estrogen’s effect on the endometrium, preventing buildup.<\/p>\n Not all progestins are equal for PCOS. Pills containing anti-androgenic progestins like drospirenone (Yasmin, Yaz) or cyproterone acetate (Diane-35, available outside the US) offer additional androgen-blocking benefits.<\/p>\n The downside: COCs can worsen insulin resistance and raise triglycerides. A 2011 meta-analysis by Amiri et al. in the European Journal of Endocrinology found that COCs improved androgen profiles but had neutral-to-negative effects on metabolic markers. They also mask symptoms without treating the underlying pathology, which means PCOS features typically return after stopping.<\/p>\n Spironolactone is an androgen receptor blocker used off-label for hirsutism and acne in PCOS. At doses of 50 to 200 mg daily, it blocks testosterone from binding to receptors in the skin and hair follicles. Results take 6 to 12 months for hirsutism and 3 to 6 months for acne.<\/p>\n Because spironolactone can feminize a male fetus, it must be used with reliable contraception. It’s often prescribed alongside an oral contraceptive for this reason. Common side effects include lightheadedness, breast tenderness, and irregular bleeding (which the OCP offsets).<\/p>\n GLP-1 medications like semaglutide (Ozempic\u00ae, Wegovy\u00ae) and tirzepatide (Mounjaro\u00ae, Zepbound\u00ae) are reshaping PCOS treatment. These drugs work on multiple levels that are specifically relevant to PCOS:<\/p>\n For PCOS specifically, the Elkind-Hirsch 2008 study published in Fertility and Sterility compared exenatide (an earlier GLP-1 agonist) combined with metformin versus metformin alone in obese women with PCOS. The combination group had significantly greater weight loss, improved menstrual cyclicity, and better ovulation rates.<\/p>\n Newer data with semaglutide and liraglutide is accumulating rapidly. A 2023 randomized controlled trial by Jensterle et al. published in the Journal of Clinical Endocrinology & Metabolism found that semaglutide 1.0 mg weekly produced greater weight loss and more significant improvements in hormonal parameters than metformin in women with PCOS over 24 weeks.<\/p>\n Insurance coverage for GLP-1 medications in PCOS patients is improving but inconsistent. Most insurers will cover these drugs if the patient meets obesity criteria (BMI 30+ or 27+ with a comorbidity like prediabetes or hypertension). PCOS itself isn’t yet an approved indication, so the prescribing is technically off-label in that context.<\/p>\n Our detailed guide to GLP-1 medications for PCOS covers the specifics of what to expect, dosing, and timeline.<\/p>\n For women trying to conceive, the treatment ladder typically goes:<\/p>\n Adding metformin to letrozole may improve outcomes in some subgroups, though evidence is mixed. GLP-1 medications are being studied as pre-conception weight loss tools, with the recommendation to stop them at least 2 months before attempting pregnancy (per the FDA label for semaglutide).<\/p>\n A few supplements have actual clinical evidence behind them for PCOS:<\/p>\n Myo-inositol has the strongest data. A 2012 meta-analysis by Unfer et al. in Gynecological Endocrinology found that myo-inositol at 4000 mg daily improved ovulation rates, insulin sensitivity, and androgen levels. The typical protocol combines myo-inositol with D-chiro-inositol in a 40:1 ratio, which mimics the body’s natural ratio.<\/p>\n Vitamin D supplementation in deficient PCOS patients (and deficiency is common, present in 67% to 85% of women with PCOS per a 2015 review) has been shown to improve insulin sensitivity and may support fertility. Doses of 1000 to 4000 IU daily are common.<\/p>\n Omega-3 fatty acids at 2 to 4 grams daily have shown modest benefits for triglycerides and inflammation in PCOS, based on a 2018 meta-analysis by Yang et al. in Archives of Gynecology and Obstetrics.<\/p>\n Berberine has been compared to metformin in a few small studies and showed similar effects on insulin resistance, but the evidence base is much smaller and the quality lower.<\/p>\n Key Takeaway: A 5-10% weight loss can restore ovulation, lower testosterone, and improve insulin sensitivity.<\/p>\n PCOS is a lifelong condition, but its expression shifts with age.<\/strong><\/p>\n Diagnosis is tricky here because irregular periods and acne are common in adolescence anyway. The 2023 international guideline recommends caution in diagnosing PCOS within the first 2 years after menarche and suggests “at risk” labeling rather than definitive diagnosis.<\/p>\n This is when most symptoms are at their peak. Fertility concerns often drive women to seek diagnosis and treatment. Metabolic risks are accumulating even when blood sugar levels look normal.<\/p>\n Androgen levels naturally decline with age, so hirsutism and acne may improve somewhat. But metabolic risks increase. A 2016 longitudinal study by Meun et al. in the Journal of Clinical Endocrinology & Metabolism found that women with PCOS in their forties had a 4-fold higher rate of type 2 diabetes and a 2-fold higher rate of metabolic syndrome compared to age-matched controls.<\/p>\n PCOS doesn’t end at menopause. Cardiovascular risk, diabetes risk, and the effects of years of insulin resistance persist. Monitoring should continue, and some women benefit from ongoing metformin or GLP-1 therapy even after reproductive concerns are no longer relevant.<\/p>\n PCOS affects mental health both directly (through hormonal and metabolic mechanisms) and indirectly (through the psychological burden of symptoms like weight gain, hair growth, acne, and infertility).<\/strong><\/p>\n The elevated rates of depression and anxiety mentioned earlier aren’t something to push through. They deserve treatment in their own right. Cognitive behavioral therapy has the best evidence for PCOS-related psychological distress. Some women also benefit from SSRIs or other psychiatric medications.<\/p>\n Body image concerns in PCOS are real and valid. The 2023 international guideline specifically calls out the importance of screening for psychological distress at every PCOS visit and refers to this as a core outcome, not an afterthought.<\/p>\n There’s no one-size-fits-all approach, but a reasonable framework:<\/p>\n Bottom line: GLP-1 medications like semaglutide produce 14.9% average weight loss over 68 weeks.<\/p>\n Misconceptions about treatment can delay good decisions. Here are three worth correcting before you make any choices about your care.<\/p>\n Myth:<\/strong> PCOS is just about ovaries and irregular periods. Fact:<\/strong> PCOS is a metabolic and endocrine disorder. 65 to 80 percent of women with PCOS have insulin resistance, and PCOS roughly doubles type 2 diabetes risk by age 40. The reproductive symptoms are often the most visible part of a wider hormonal picture.<\/p>\n Myth:<\/strong> If you have PCOS, you can’t lose weight. Fact:<\/strong> Weight loss is harder with PCOS due to insulin resistance, but it’s possible. Even 5 to 10 percent weight loss can restore ovulation. GLP-1 medications produce comparable weight loss in PCOS patients to those without it.<\/p>\n Myth:<\/strong> Birth control is the only PCOS treatment. Fact:<\/strong> Oral contraceptives manage symptoms but don’t address the underlying insulin resistance. Metformin, inositol, and GLP-1 medications target the metabolic root, often producing broader symptom improvement.<\/p>\n Managing your metabolic health shouldn’t be a journey you take alone. The science behind GLP-1 medications offers a new level of hope for people facing pcos and the related challenges that come with it. By addressing root hormonal and metabolic causes, these treatments provide a path toward more stable energy, better cardiovascular health, and improved quality of life.<\/p>\n At TrimRx, we’re committed to providing an empathetic and transparent experience. We understand the frustrations of traditional healthcare: the long waits, the unclear costs, and the lack of personalized care. Our platform is designed to put you back in control of your health. By combining clinical expertise with modern technology, we help you access the treatments you need while providing the 24\/7 support you deserve.<\/p>\n Our program includes:<\/p>\n Sustainable health is about more than a number on a scale or a single lab result. It’s about feeling empowered in your own body. Whether you’re starting to research your options or ready to take the next step with a free assessment, we’re here to guide you with science-backed, personalized care.<\/p>\n Bottom line:<\/strong> TrimRx provides a streamlined, medically supervised path to access the latest advancements in pcos and weight management, all from the comfort of home.<\/p>\n No. PCOS is a chronic condition without a cure. But it can be managed effectively to the point where symptoms are minimal and metabolic risks are well controlled. Many women with PCOS live completely normal lives with proper treatment. The goal isn’t elimination; it’s management.<\/p>\n Weight loss doesn’t cure PCOS, but it’s the single most impactful intervention for most women who are above a healthy weight range. Losing 5% to 10% of body weight has been shown to restore ovulatory cycles in up to 75% of anovulatory women with PCOS, according to a 2011 review by Moran et al. in Human Reproduction Update. Insulin sensitivity, androgen levels, and cardiovascular risk markers all improve too.<\/p>\n Not specifically. Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management in adults with BMI 30+ or BMI 27+ with a weight-related comorbidity. Many women with PCOS meet these criteria. The use of GLP-1 medications for PCOS-specific benefits like improved ovulation or androgen reduction is considered off-label, though the evidence supporting it is growing. Insurance coverage typically depends on meeting the BMI threshold, not the PCOS diagnosis.<\/p>\n It depends on what you’re treating. Menstrual cycle improvements with metformin or weight loss typically appear within 3 to 6 months. Acne responds to OCPs or spironolactone in 3 to 6 months. Hirsutism is the slowest, often taking 6 to 12 months to see improvement because hair follicles have a long growth cycle. GLP-1 medications produce noticeable weight loss within the first 4 to 8 weeks, with metabolic improvements following.<\/p>\n There’s a strong genetic component. First-degree relatives of women with PCOS have a 40% to 50% risk of developing the condition. Twin studies show heritability of 70% or higher. But it’s not a single-gene disorder. It involves many genetic variants, each with a small effect, interacting with environmental factors like diet, stress, and endocrine disruptors. Having a mother or sister with PCOS doesn’t guarantee you’ll develop it, but it does mean you should be screened if symptoms appear.<\/p>\n Yes. Approximately 20% to 30% of women with PCOS are normal weight or lean. Lean PCOS tends to present with more androgen-driven symptoms (hirsutism, acne, irregular periods) and less obvious metabolic disruption, but insulin resistance can still be present. A 2020 study by Sachdeva et al. in the Indian Journal of Endocrinology and Metabolism found that 46% of lean PCOS patients had insulin resistance when tested with HOMA-IR, versus 17% of lean controls.<\/p>\n Women with PCOS have a 4 to 8 times higher risk of developing type 2 diabetes compared to age-matched women without PCOS, according to the 2023 international guideline. The risk exists even in normal-weight women with PCOS, though it’s higher in those who are overweight. Regular screening with A1c or oral glucose tolerance testing is recommended starting at diagnosis, or by age 30 at the latest.<\/p>\n Yes. Beyond the difficulty conceiving, women with PCOS who do become pregnant face higher rates of gestational diabetes (2 to 3 times higher risk), preeclampsia, preterm birth, and cesarean delivery. Preconception optimization of weight and metabolic markers can reduce, though not eliminate, these risks. The 2023 guideline recommends metformin during pregnancy for women with PCOS who have gestational diabetes risk factors, though practice varies by provider.<\/p>\n This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider for diagnosis and treatment of PCOS. TrimRX providers are available for telehealth consultations regarding PCOS and weight management.<\/em><\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n","protected":false},"excerpt":{"rendered":" Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting roughly 1 in 10 worldwide.<\/p>\n","protected":false},"author":11,"featured_media":76664,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[7],"tags":[],"class_list":["post-76665","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-semaglutide"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/76665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=76665"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/76665\/revisions"}],"predecessor-version":[{"id":76843,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/76665\/revisions\/76843"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/76664"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=76665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=76665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=76665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}How Common Is PCOS Really?<\/h3>\n
What About the Name Itself?<\/h3>\n
Why Does Insulin Resistance Matter So Much in PCOS?<\/h2>\n
What Does Insulin Resistance Feel Like?<\/h3>\n
\n
What Are the Main Symptoms of PCOS?<\/h2>\n
Irregular or Absent Periods<\/h3>\n
Excess Hair Growth (Hirsutism)<\/h3>\n
Acne and Oily Skin<\/h3>\n
Weight Gain and Difficulty Losing Weight<\/h3>\n
Hair Thinning and Androgenic Alopecia<\/h3>\n
Infertility<\/h3>\n
Mental Health Effects<\/h3>\n
Why Is Weight Management So Central to PCOS Treatment?<\/h2>\n
What Are the Treatment Options for PCOS?<\/h2>\n
Lifestyle Modifications<\/h3>\n
Metformin<\/h3>\n
Oral Contraceptives<\/h3>\n
Spironolactone<\/h3>\n
GLP-1 Receptor Agonists<\/h3>\n
\n
Fertility Treatments<\/h3>\n
\n
Supplements with Evidence<\/h3>\n
How Does PCOS Change Over Time?<\/h2>\n
Teens and EARLY Twenties<\/h3>\n
Reproductive Years (Twenties and Thirties)<\/h3>\n
Late Thirties and Forties<\/h3>\n
Perimenopause and Beyond<\/h3>\n
What About the Mental Health Side?<\/h2>\n
What Should a Treatment Plan Look Like?<\/h2>\n
\n
\n
\n
\n
\n
\n
\n
Myth vs. Fact: Setting the Record Straight<\/h2>\n
The Path Forward with TrimRx<\/h2>\n
\n
FAQ<\/h2>\n
Can You Cure PCOS?<\/h3>\n
Does Losing Weight Fix PCOS?<\/h3>\n
Are GLP-1 Medications Approved for PCOS?<\/h3>\n
How Long Does It Take for PCOS Treatment to Work?<\/h3>\n
Is PCOS Genetic?<\/h3>\n
Can Thin Women Have PCOS?<\/h3>\n
What’s the Connection Between PCOS and Diabetes?<\/h3>\n
Does PCOS Affect Pregnancy Outcomes?<\/h3>\n